Erratum to: Managing Cardiovascular Risk in Lysosomal Acid Lipase Deficiency. - Suppr | 超能文献

Erratum to: Managing Cardiovascular Risk in Lysosomal Acid Lipase Deficiency.

作者信息

Maciejko James J

机构信息

Division of Cardiology, St. John Hospital and Medical Center, 22101 Moross Road, Detroit, MI, 48236, USA.

Department of Internal Medicine, Wayne State University School of Medicine, 540 East Canfield, Detroit, MI, 48201, USA.

出版信息

Am J Cardiovasc Drugs. 2017 Jun;17(3):233. doi: 10.1007/s40256-017-0228-1.

DOI:10.1007/s40256-017-0228-1

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Erratum to: Managing Cardiovascular Risk in Lysosomal Acid Lipase Deficiency.

Am J Cardiovasc Drugs. 2017 Jun;17(3):233. doi: 10.1007/s40256-017-0228-1.

2

Managing Cardiovascular Risk in Lysosomal Acid Lipase Deficiency.溶酶体酸性脂肪酶缺乏症中心血管风险的管理

Am J Cardiovasc Drugs. 2017 Jun;17(3):217-231. doi: 10.1007/s40256-017-0216-5.

3

Lysosomal acid lipase deficiency--an under-recognized cause of dyslipidaemia and liver dysfunction.溶酶体酸性脂肪酶缺乏症——一种被低估的血脂异常和肝功能障碍的病因。

Atherosclerosis. 2014 Jul;235(1):21-30. doi: 10.1016/j.atherosclerosis.2014.04.003. Epub 2014 Apr 15.

4

Sebelipase alfa: enzymatic replacement treatment for lysosomal acid lipase deficiency.塞贝利酶α：用于溶酶体酸性脂肪酶缺乏症的酶替代疗法。

Drugs Today (Barc). 2016 May;52(5):287-93. doi: 10.1358/dot.2016.52.5.2488974.

5

Diagnostic and therapeutic management of children with lysosomal acid lipase deficiency (LAL-D). Review of the literature and own experience.溶酶体酸性脂肪酶缺乏症（LAL-D）患儿的诊断与治疗管理。文献综述及自身经验。

Dev Period Med. 2016;20(3):212-215.

6

[Acid lipase deficiency: Wolman disease and cholesteryl ester storage disease].[酸性脂肪酶缺乏症：沃尔曼病和胆固醇酯贮积病]

Nihon Rinsho. 1995 Dec;53(12):3004-8.

7

A case of acid lipase deficiency: Wolman's disease.一例酸性脂肪酶缺乏症：沃尔曼病。

Panminerva Med. 1989 Jan-Mar;31(1):49-53.

8

Reversal of advanced disease in lysosomal acid lipase deficient mice: a model for lysosomal acid lipase deficiency disease.溶酶体酸性脂肪酶缺乏症小鼠的晚期疾病逆转：溶酶体酸性脂肪酶缺乏症模型。

Mol Genet Metab. 2014 Jul;112(3):229-41. doi: 10.1016/j.ymgme.2014.04.006. Epub 2014 May 4.

9

Extended use of a selective inhibitor of acid lipase for the diagnosis of Wolman disease and cholesteryl ester storage disease.酸性脂肪酶选择性抑制剂的延长使用在沃曼病和胆固醇酯贮积症的诊断中的应用。

Gene. 2014 Apr 10;539(1):154-6. doi: 10.1016/j.gene.2014.02.003. Epub 2014 Feb 6.

10

Genetic lipid storage disease with lysosomal acid lipase deficiency in rats.大鼠中伴有溶酶体酸性脂肪酶缺乏的遗传性脂质贮积病

Lab Anim Sci. 1990 Sep;40(5):486-9.

引用本文的文献

1

Optimization of novel halophilic lipase production by strain NFCCL 4084 using palm oil mill effluent.利用棕榈油厂废水优化菌株NFCCL 4084产新型嗜盐脂肪酶的条件

J Genet Eng Biotechnol. 2018 Dec;16(2):327-334. doi: 10.1016/j.jgeb.2018.04.003. Epub 2018 Apr 27.